Onconetix Inc (ONCO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.15M
Last updated: Nov 17, 2026 at 11:05 AM ET
Onconetix Inc (ONCO) Competitors
The companies most similar to Onconetix are Imunon (IMNN), XORTX Therapeutics (XRTX) and Curis (CRIS). By market cap, Onconetix ranks 8th of the 13 companies on this page; CNS Pharmaceuticals (CNSP) is the largest at $4.22M.
Peer Comparison
ONCO's revenue growth of -83.9% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Onconetix (ONCO) | $2.15M | N/A | 1.0x | 0.0% | N/A | -83.9% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| XORTX Therapeutics Inc (XRTX) | $2.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| HCW Biologics Inc (HCWB) | $1.73M | N/A | 0.2x | -83.1% | -51.6% | 1970.0% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Genprex Inc (GNPX) | $1.71M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Kairos Pharma, Ltd. (KAPA) | $1.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Scinai Immunotherapeutics Ltd (SCNI) | $1.05M | N/A | N/A | -80.1% | N/A | 572.0% | 0.00% |
| CNS Pharmaceuticals Inc (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Neurosense Therapeutics Ltd (NRSN) | $3.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $2.56M | N/A | 0.9x | 0.0% | -91.6% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Onconetix, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| XORTX Therapeutics Inc (XRTX) | XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease... | XRTX competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| HCW Biologics Inc (HCWB) | HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues... | HCWB competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| Genprex Inc (GNPX) | Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. | GNPX competitors |
| Kairos Pharma, Ltd. (KAPA) | Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. | KAPA competitors |
| Scinai Immunotherapeutics Ltd (SCNI) | Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune... | SCNI competitors |
| CNS Pharmaceuticals Inc (CNSP) | CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central... | CNSP competitors |
| Neurosense Therapeutics Ltd (NRSN) | Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases... |
Frequently Asked Questions About ONCO
Who are Onconetix's main competitors?
The companies most similar to Onconetix include Imunon (IMNN), XORTX Therapeutics (XRTX), Curis (CRIS), Ernexa Therapeutics (ERNA) and HCW Biologics (HCWB), listed from the closest match.
Who is Onconetix's biggest competitor?
CNS Pharmaceuticals (CNSP) is the largest of the similar companies at $4.22M; Imunon (IMNN) is the closest match by business profile, size, sector and industry.
How does ONCO stock compare with its competitors?
ONCO's P/S is 1.0x against a peer median of 0.9x; its net margin is 0.0% against a peer median of 0.0%.
Which of Onconetix's competitors pays a higher dividend?
Onconetix pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Onconetix bigger than its competitors?
No. Onconetix is 8th by market cap among the 13 companies on this page; the largest is CNS Pharmaceuticals (CNSP) at $4.22M.
ONCO pages: Overview, Financials, Competitors